首页 | 本学科首页   官方微博 | 高级检索  
     


Upfront autologous hematopoietic stem cell transplantation consolidation for patients with aggressive B-cell lymphomas in first remission in the rituximab era: A systematic review and meta-analysis
Authors:Narendranath Epperla MD  MS  Mehdi Hamadani MD  Tea Reljic MPH  Mohamed A. Kharfan-Dabaja MD  MBA  Bipin N. Savani MD  Ambuj Kumar MD  MPH
Affiliation:1. Division of Hematology, Department of Medicine, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, Ohio;2. Blood and Marrow Transplant (BMT) and Cellular Therapy Program, Medical College of Wisconsin, Milwaukee, Wisconsin;3. Program for Comparative Effectiveness Research, Morsani College of Medicine, University of South Florida, Tampa, Florida;4. Blood and Marrow Transplantation Program, Division of Hematology/Oncology, Mayo Clinic, Jacksonville, Florida;5. Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee
Abstract:
Keywords:aggressive B-cell lymphoma  autologous hematopoietic stem cell transplantation  meta-analysis  International Prognostic Index (IPI)  rituximab
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号